Skip to main content

Advertisement

SpringerLink
Log in

ASO Author Reflections: Pancreatic Cancer Having Tumor Contact with an Aberrant Right Hepatic Artery Should be Regarded as Technically Resectable but Oncologically Borderline-Resectable

  • ASO Author Reflections
  • Published:
Annals of Surgical Oncology Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

References

  1. Okada K, Kawai M, Hirono S, et al. A replaced right hepatic artery adjacent to pancreatic carcinoma should be divided to obtain R0 resection in pancreaticoduodenectomy. Langenbecks Arch Surg. 2015;400:57–65.

    Article  Google Scholar 

  2. Turrini O, Wiebke EA, Delpero JR, Viret F, Lillemoe KD, Schmidt CM. Preservation of replaced or accessory right hepatic artery during pancreaticoduodenectomy for adenocarcinoma: impact on margin status and survival. J Gastrointest Surg. 2010;14:1813–9.

    Article  Google Scholar 

  3. Asano T, Nakamura T, Noji T, et al. Outcome of concomitant resection of the replaced right hepatic artery in pancreaticoduodenectomy without reconstruction. Langenbecks Arch Surg. 2018;403:195–202.

    PubMed  Google Scholar 

  4. National Comprehensive Cancer Network. NCCN Clinical Practice Guidelines in Oncology. Pancreatic Adenocarcinoma. version 1.2021. Available at: https://www2.tri-kobe.org/nccn/guideline/pancreas/english/pancreatic.pdf. Accessed 1 Mar 2022.

  5. Miura Y, Ohgi K, Sugiura T, et al. Resectability status of pancreatic cancer having tumor contact with an aberrant right hepatic artery: is upfront surgery justified? Ann Surg Oncol. 2022. https://doi.org/10.1245/s10434-022-11624-y.

Download references

Author information

Authors and Affiliations

  1. Division of Hepato-Biliary-Pancreatic Surgery, Shizuoka Cancer Center, Shizuoka, Japan

    Yuya Miura MD, Katsuhisa Ohgi MD, Teiichi Sugiura MD, Yukiyasu Okamura MD, Ryo Ashida MD, Mihoko Yamada MD, Shimpei Otsuka MD & Katsuhiko Uesaka MD

  2. Division of Plastic and Reconstructive Surgery, Shizuoka Cancer Center, Shizuoka, Japan

    Yoshichika Yasunaga MD & Masahiro Nakagawa MD

Authors
  1. Yuya Miura MD
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Katsuhisa Ohgi MD
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Teiichi Sugiura MD
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Yukiyasu Okamura MD
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Ryo Ashida MD
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Mihoko Yamada MD
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. Shimpei Otsuka MD
    View author publications

    You can also search for this author in PubMed Google Scholar

  8. Yoshichika Yasunaga MD
    View author publications

    You can also search for this author in PubMed Google Scholar

  9. Masahiro Nakagawa MD
    View author publications

    You can also search for this author in PubMed Google Scholar

  10. Katsuhiko Uesaka MD
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Katsuhisa Ohgi MD.

Ethics declarations

Disclosures

Yuya Miura, Katsuhisa Ohgi, Teiichi Sugiura, Yukiyasu Okamura, Ryo Ashida, Mihoko Yamada, Shimpei Otsuka, Yoshichika Yasunaga, Masahiro Nakagawa, and Katsuhiko Uesaka declare no conflicts of interest.

Additional information

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Miura, Y., Ohgi, K., Sugiura, T. et al. ASO Author Reflections: Pancreatic Cancer Having Tumor Contact with an Aberrant Right Hepatic Artery Should be Regarded as Technically Resectable but Oncologically Borderline-Resectable. Ann Surg Oncol 29, 4989–4990 (2022). https://doi.org/10.1245/s10434-022-11639-5

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1245/s10434-022-11639-5

Search

Navigation